Melissa J. Moore PhD, Chief Scientific Officer at Moderna recaps in a 2022 TED Talk that as soon as Chinese novel-CoV virus gene sequence was made public on January 10, 2020, they “got immediately to work”. [1, 2]

Within 2 days, following discussions with their National Institutes of Health (NIH) partners, they agreed on “which form of spike protein they’d put in their vaccines”.  So on January 12, 2020 it “took Moderna’s mRNA design team just one hour to design” the modified mRNA vaccine sequence which was immediately put onto their manufacturing equipment and used in their phase 1 trials.

Remember, Moderna had never brought a product to market and the FDA considered mRNA as a “gene therapy“, yet by 2022 Moore refered to the use of their technology as a “vaccine” when used in a few trial patients who already had cancer (not as a preventative!).

“By January of 2020, we had already manufactured, quality controlled and delivered to several dozen patients personalised cancervaccines. So we had the know-how and the capacity to manufacture vaccines quickly.”

“There is a coming Tsunami of mRNA medicine” [called vaccines?]